Epyztek
Australian Public Assessment Report
Device/Product Name
Epyztek
Active ingredients
Ustekinumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-04204-1-1
Submission Type
New biosimilar medicine
Decision
Approved